HEALTH● LOWAug 20 · Aug 20, 2026, 6:30 PM
Experimental Drug Generates Immune Response Against Pancreatic Cancer in People at High Risk
GNN Science
Researchers at Johns Hopkins report that an experimental drug targeting one of the most common genetic drivers of pancreatic cancer was safe in humans, and generated durable immune responses aimed at preventing the cancer in people at high risk. Pancreatic cancer has one of the lowest survival rates of any form, and the developers believe […] The post Experimental Drug Generates Immune Response Against Pancreatic Cancer in People at High Risk appeared first on Good News Network.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH37m agoUniversity of Maryland doctor explains postpartum psychosiswbaltv.com · United StatesHEALTH37m agoAntioch expands access to opioid treatment and recovery serviceseastbaytimes.com · United StatesHEALTH1h agoHow a blood donor saved a happy couple wedding daytenterfieldstar.com.au · AustraliaHEALTH1h agoFaster and cheaper: why Hongkongers are heading north for medical careSouth China Morning Post